These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 7945540)

  • 1. Clastogenicity of triazinoindole derivatives in relation with the physicochemical properties of the substituents.
    García E; Lopez-de-Cerain A; Garrido E; Gullón A; Monge A
    Arzneimittelforschung; 1994 Aug; 44(8):953-6. PubMed ID: 7945540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial mutagenic evaluation of a series of 4' substituted derivatives of 3-benzylidenamino-5H-1,2,3-triazin[5,4b]indol-4-one.
    García E; Lopez-de-Cerain A; Gullón A; Arrarás JA; Monge A
    Mutagenesis; 1992 Jan; 7(1):31-5. PubMed ID: 1635453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the triazine ring on the mutagenicity of triazinoindoles and some congeners.
    Lopez-de-Cerain A; García E; Gullón A
    Mutagenesis; 1992 Jan; 7(1):37-9. PubMed ID: 1635454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-mutagenic activity relationships of triazino indole derivatives.
    García E; Lopez-de-Cerain A; Martinez-Merino V; Monge A
    Mutat Res; 1992 Jul; 268(1):1-9. PubMed ID: 1378175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells.
    Dufour EK; Kumaravel T; Nohynek GJ; Kirkland D; Toutain H
    Mutat Res; 2006 Sep; 607(2):215-24. PubMed ID: 16797222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mediation of mutagenicity and clastogenicity of heavy metals by physicochemical factors.
    Babich H; Devanas MA; Stotzky G
    Environ Res; 1985 Aug; 37(2):253-86. PubMed ID: 3894000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the mutagenicity of 1-hydrazino-4-(3,5-dimethyl-1-pyrazolyl) pyridazino[4,5-b]indole.
    Lopez-de Cerain A; García E; Gullón A; Alvarez T; Losa MJ; Monge A
    Arzneimittelforschung; 1994 Mar; 44(3):310-2. PubMed ID: 8192696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-clastogenic effect of magnolol on benzo(a)pyrene-induced clastogenicity in mice.
    Saito J; Shibuya K; Nagase H
    Food Chem Toxicol; 2008 Feb; 46(2):694-700. PubMed ID: 17967502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro clastogenicity of optical isomers of nadifloxacin.
    Takahashi N; Shiragiku T; Itoh T; Kaneko E; Shibahara T; Kanbe T; Yamashita S
    Arzneimittelforschung; 1994 Nov; 44(11):1265-8. PubMed ID: 7848343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
    Shibata K; Matsuda K; Ohta T; Sasaki Y; Sutou S
    Arzneimittelforschung; 1991 Oct; 41(10):1053-7. PubMed ID: 1799383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals.
    Mekenyan O; Todorov M; Serafimova R; Stoeva S; Aptula A; Finking R; Jacob E
    Chem Res Toxicol; 2007 Dec; 20(12):1927-41. PubMed ID: 18052113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity study of the new cephalosporin antibiotic cefditoren pivoxil.
    Shindo Y; Hayashi H; Ando M; Tatebayashi T
    Arzneimittelforschung; 1996 Aug; 46(8):815-21. PubMed ID: 9125285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the clastogenicity of fumagillin.
    Stevanovic J; Stanimirovic Z; Radakovic M; Stojic V
    Environ Mol Mutagen; 2008 Oct; 49(8):594-601. PubMed ID: 18613037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo study of the clastogenicity of the flavone cirsitakaoside extracted from Scoparia dulcis L. (Scrophulariaceae).
    Pereira-Martins SR; Takahashi CS; Tavares DC; Torres LM
    Teratog Carcinog Mutagen; 1998; 18(6):293-302. PubMed ID: 10052564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
    Witte I; Plappert U; de Wall H; Hartmann A
    Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutagenicity studies of miporamicin].
    Sono A; Oyaide K; Suzuki A; Kobayashi Y; Matsumoto K; Yamamoto H
    Jpn J Antibiot; 1989 Nov; 42(11):2506-12. PubMed ID: 2621789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative aspects of the relationship of the antitumor activity and toxicity of diaziridinyl-sym. triazines to their physicochemical properties].
    Ivin BA; Filov VA; Kraĭz BO; Belogorodskiĭ VV; Maliugina LL
    Vopr Onkol; 1979; 25(7):71-5. PubMed ID: 483685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity assessment of acrylate and methacrylate compounds and implications for regulatory toxicology requirements.
    Johannsen FR; Vogt B; Waite M; Deskin R
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):322-35. PubMed ID: 18346829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial and genotoxic properties of quinoline derivatives.
    Zani F; Carmellino ML
    Boll Chim Farm; 1994 May; 133(5):328-38. PubMed ID: 8068239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazinoindole analogs as potent inhibitors of α-glucosidase: synthesis, biological evaluation and molecular docking studies.
    Rahim F; Ullah K; Ullah H; Wadood A; Taha M; Ur Rehman A; uddin I; Ashraf M; Shaukat A; Rehman W; Hussain S; Khan KM
    Bioorg Chem; 2015 Feb; 58():81-7. PubMed ID: 25528720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.